These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Small molecule inhibitors of KDR (VEGFR-2) kinase: an overview of structure activity relationships. Boyer SJ Curr Top Med Chem; 2002 Sep; 2(9):973-1000. PubMed ID: 12171566 [TBL] [Abstract][Full Text] [Related]
3. Inhibitors of the vascular endothelial growth factor receptor. Rosen LS Hematol Oncol Clin North Am; 2002 Oct; 16(5):1173-87. PubMed ID: 12512388 [TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules. Zachary I IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611 [TBL] [Abstract][Full Text] [Related]
5. Regulators of angiogenesis as targets for anti-angiogenic tumor therapy. Breier G; Heidenreich R; Gaumann A; Groot M; Licht A; Nicolaus A; Schmitz J; Reichmann E; Plate KH; Vajkoczy P Ann Hematol; 2002; 81 Suppl 2():S71-2. PubMed ID: 12611084 [No Abstract] [Full Text] [Related]
7. Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptors. Kojima-Yuasa A; Hua JJ; Kennedy DO; Matsui-Yuasa I Life Sci; 2003 Jul; 73(10):1299-313. PubMed ID: 12850245 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis. Haspel HC; Scicli GM; McMahon G; Scicli AG Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307 [TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic agents targeting vascular endothelial growth factor and its receptors in clinical development. Sepp-Lorenzino L; Thomas KA Expert Opin Investig Drugs; 2002 Oct; 11(10):1447-65. PubMed ID: 12387705 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications. Ellis LM; Takahashi Y; Liu W; Shaheen RM Oncologist; 2000; 5 Suppl 1():11-5. PubMed ID: 10804085 [TBL] [Abstract][Full Text] [Related]
11. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells. Miura S; Matsuo Y; Saku K Hypertension; 2003 May; 41(5):1118-23. PubMed ID: 12654712 [TBL] [Abstract][Full Text] [Related]
12. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Ushio-Fukai M; Tang Y; Fukai T; Dikalov SI; Ma Y; Fujimoto M; Quinn MT; Pagano PJ; Johnson C; Alexander RW Circ Res; 2002 Dec; 91(12):1160-7. PubMed ID: 12480817 [TBL] [Abstract][Full Text] [Related]
13. Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Koyanagi S; Tanigawa N; Nakagawa H; Soeda S; Shimeno H Biochem Pharmacol; 2003 Jan; 65(2):173-9. PubMed ID: 12504793 [TBL] [Abstract][Full Text] [Related]